Laminin alpha2 chain-positive vessels and epidermal growth factor in lung neuroendocrine carcinoma: a model of a novel cooperative role of laminin-2 and epidermal growth factor in vessel neoplastic invasion and metastasis.
Capillaries expressing the laminin alpha2 chain in basement membranes may be considered early developing vessels in normal and neoplastic human tissues. Therefore, we investigated whether up-regulation of this extracellular matrix protein favors transendothelial migration of neoplastic cells and then metastasis. In lung small and large cell neuroendocrine carcinomas, which exhibit a stronger metastatic tendency among carcinomas, laminin alpha2 chain-positive vessels were more numerous than in carcinoid tumors and supraglottis, breast, and lung non-small cell carcinomas, suggesting a direct relationship between these vessels and metastasis. In vitro studies showed that epidermal growth factor (EGF) induced a more efficient migration of the AE-2 lung neuroendocrine carcinoma cell line through the purified laminin alpha2 chain rather than through the laminin beta1 chain and fibronectin. AE-2 cells constitutively expressed all EGF receptors and the alpha6beta1 integrin, which is one of the laminin alpha2 chain receptors. EGF up-regulated alpha6beta1 expression in several tumors. In this regard, we show that EGF increased the chemo-kinetic migration of AE-2 cells through EAHY endothelial monolayers, which was inhibited by the anti-alpha6 integrin chain monoclonal antibody. These data indicate that laminin alpha2 chain and alpha6beta1 may be mutually involved in EGF-dependent migration of AE-2 cells and that laminin alpha2 chain-positive vessels may favor metastasis of EGF-dependent tumors.
Vitolo
Domenico
D
Department of Experimental Medicine and Pathology, University of Rome La Sapienza, Rome, Italy. domenico.vitolo@uniroma1.it
Ciocci
Luciano
L
Deriu
Gloria
G
Spinelli
Silvia
S
Cortese
Stefania
S
Masuelli
Laura
L
Morrone
Stefania
S
Filice
Mary Jo
MJ
Coloni
Giorgio Furio
GF
Natali
Pier Giorgio
PG
Baroni
Carlo Davide
CD
D000911:Antibodies, Monoclonal / Q000494:pharmacology; D002196:Capillaries / Q000737:chemistry; D002276:Carcinoid Tumor / Q000098:blood supply / Q000378:metabolism / Q000473:pathology; D018278:Carcinoma, Neuroendocrine / Q000098:blood supply / Q000378:metabolism / Q000473:pathology*; D045744:Cell Line, Tumor; D002465:Cell Movement; D004815:Epidermal Growth Factor / Q000235:genetics / Q000378:metabolism*; D015870:Gene Expression; D006801:Humans; D007797:Laminin / Q000032:analysis / Q000037:antagonists & inhibitors / Q000378:metabolism*; D008175:Lung Neoplasms / Q000098:blood supply / Q000378:metabolism / Q000473:pathology*; D008954:Models, Biological; D009361:Neoplasm Invasiveness; D009362:Neoplasm Metastasis; D015854:Up-Regulation
D000911:Antibodies, Monoclonal; D007797:Laminin; C102645:laminin alpha 2; D004815:Epidermal Growth Factor